1
Clinical Trials associated with Human umbilical cord mesenchymal stem cells(Nanfang Hospital)A Randomized-controlled Clinical Trial to Treat Chinese Advanced AGA With Umbilical Cord-derived Mesenchymal Stem Cell Exosomes
A total of 50 patients with androgenetic alopecia were selected for the study. Patients who met the inclusion/exclusion criteria were randomly assigned to groups A and B in a 1:1 ratio to receive treatment, with the enrollment date designated as Day 1. Group A visited the clinic once each in the first, second, and third months for treatment with exosomes, while Group B visited the clinic twice each in the first, second, and third months for treatment with exosomes. At the time points of 1, 2, 3, and 6 months after the start of the treatment period, dermatoscopic examinations were conducted on patients in both groups. The differences in hair growth density, hair shaft thickness, and follicle counts within a 1 cm diameter area were compared between the two groups. Additionally, the data differences for each subject at baseline and at the end of the experiment were also assessed.
100 Clinical Results associated with Human umbilical cord mesenchymal stem cells(Nanfang Hospital)
100 Translational Medicine associated with Human umbilical cord mesenchymal stem cells(Nanfang Hospital)
100 Patents (Medical) associated with Human umbilical cord mesenchymal stem cells(Nanfang Hospital)
100 Deals associated with Human umbilical cord mesenchymal stem cells(Nanfang Hospital)